Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

William H Stuart

Showing results (1-10 of 11) with videos related to

Pageof 2
Sort By:
Current Medical Research and Opinion|June 15, 2007
Combination therapy for the treatment of multiple sclerosis: challenges and opportunitiesWilliam H Stuart
Journal of Managed Care Pharmacy : JMCP|July 16, 2004
Clinical management of multiple sclerosis: the treatment paradigm and issues of patient managementWilliam H Stuart
Neurology|December 15, 2004
Concomitant therapy for multiple sclerosisWilliam H Stuart, Patrick Vermersch
Neurology|December 15, 2004
Selecting a disease-modifying agent as platform therapy in the long-term management of multiple sclerosisWilliam H Stuart, Stanley Cohan, John R Richert, et al.
Archives of Neurology|April 13, 2011
Efficacy of natalizumab therapy in patients of African descent with relapsing multiple sclerosis: analysis of AFFIRM and SENTINEL dataBruce A C Cree, William H Stuart, Carlo S Tornatore, et al.
Journal of Neurology|October 20, 2011
Additional efficacy endpoints from pivotal natalizumab trials in relapsing-remitting MSBianca Weinstock-Guttman, Steven L Galetta, Gavin Giovannoni, et al.
Journal of Managed Care Pharmacy : JMCP|July 16, 2004
Stepped-care approach to treating MS: a managed care treatment algorithmSheldon R Rich, Imelda C Coleman, Richard Cook, et al.
The New England Journal of Medicine|March 3, 2006
Natalizumab plus interferon beta-1a for relapsing multiple sclerosisRichard A Rudick, William H Stuart, Peter A Calabresi, et al.
Journal of the Neurological Sciences|March 19, 2010
Natalizumab plus interferon beta-1a reduces lesion formation in relapsing multiple sclerosisErnst-Wilhelm Radue, William H Stuart, Peter A Calabresi, et al.
Journal of Neurology|March 25, 2009
The efficacy of natalizumab in patients with relapsing multiple sclerosis: subgroup analyses of AFFIRM and SENTINELMichael Hutchinson, Ludwig Kappos, Peter A Calabresi, et al.
Pageof 2

Showing results (1-10 of 11) with videos related to

Sort By:
Pageof 2
Current Medical Research and Opinion|June 15, 2007
Combination therapy for the treatment of multiple sclerosis: challenges and opportunitiesWilliam H Stuart
Journal of Managed Care Pharmacy : JMCP|July 16, 2004
Clinical management of multiple sclerosis: the treatment paradigm and issues of patient managementWilliam H Stuart
Neurology|December 15, 2004
Concomitant therapy for multiple sclerosisWilliam H Stuart, Patrick Vermersch
Neurology|December 15, 2004
Selecting a disease-modifying agent as platform therapy in the long-term management of multiple sclerosisWilliam H Stuart, Stanley Cohan, John R Richert, et al.
Archives of Neurology|April 13, 2011
Efficacy of natalizumab therapy in patients of African descent with relapsing multiple sclerosis: analysis of AFFIRM and SENTINEL dataBruce A C Cree, William H Stuart, Carlo S Tornatore, et al.
Journal of Neurology|October 20, 2011
Additional efficacy endpoints from pivotal natalizumab trials in relapsing-remitting MSBianca Weinstock-Guttman, Steven L Galetta, Gavin Giovannoni, et al.
Journal of Managed Care Pharmacy : JMCP|July 16, 2004
Stepped-care approach to treating MS: a managed care treatment algorithmSheldon R Rich, Imelda C Coleman, Richard Cook, et al.
The New England Journal of Medicine|March 3, 2006
Natalizumab plus interferon beta-1a for relapsing multiple sclerosisRichard A Rudick, William H Stuart, Peter A Calabresi, et al.
Journal of the Neurological Sciences|March 19, 2010
Natalizumab plus interferon beta-1a reduces lesion formation in relapsing multiple sclerosisErnst-Wilhelm Radue, William H Stuart, Peter A Calabresi, et al.
Journal of Neurology|March 25, 2009
The efficacy of natalizumab in patients with relapsing multiple sclerosis: subgroup analyses of AFFIRM and SENTINELMichael Hutchinson, Ludwig Kappos, Peter A Calabresi, et al.
Pageof 2